Effect of once-weekly subcutaneous semaglutide 2.4 mg on weight- and health-related quality of life in an East Asian population: Patient-reported outcomes from the STEP 6 trial.

Kolotkin, Ronette L; Jeppesen, Ole Kleist; Baker-Knight, James; Lee, Sang Yeoup; Tokita, Asako; Kadowaki, Takashi

Effect of once-weekly subcutaneous semaglutide 2.4 mg on weight- and health-related quality of life in an East Asian population: Patient-reported outcomes from the STEP 6 trial.

Kolotkin, Ronette L; Jeppesen, Ole Kleist; Baker-Knight, James; Lee, Sang Yeoup; Tokita, Asako; Kadowaki, Takashi.

Afiliación

Kolotkin RL; Quality of Life Consulting, Durham, North Carolina, USA.
Jeppesen OK; Family Medicine and Community Health, Duke University School of Medicine, Durham, North Carolina, USA.
Baker-Knight J; Centre of Health Research, Helse Førde Hospital Trust, Førde, Norway.
Lee SY; Morbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, Norway.
Tokita A; Novo Nordisk A/S, Søborg, Denmark.
Kadowaki T; Novo Nordisk A/S, Søborg, Denmark.

Clin Obes ; 13(4): e12589, 2023 Aug.

Article en En | MEDLINE | ID: mdl-36905345

Asunto(s)

Diabetes Mellitus Tipo 2; Calidad de Vida; Adulto; Humanos; Pueblos del Este de Asia; Obesidad/psicología; Medición de Resultados Informados por el Paciente

Palabras clave

East Asian; IWQOL-Lite-CT; SF-36v2; obesity; patient-reported outcomes; semaglutide

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Clin Obes Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google